By Kris Gustafson, Vice President, Global Head Patient Centered Technologies
Electronic Clinical Outcomes Assessments (eCOAs) gained new popularity during the pandemic, as sponsors sought more agile tools to help them capture patient data remotely. These digital assessments make it easy for investigators and sponsors to keep track of patient progress outside of the confines of the site environment, and to collect more patient-specific information to support the safety and efficacy of a treatment and its impact on patients’ quality of life.
We predict that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings. Their use will be shaped by the following three trends that promise to make these assessments even more useful in the years to come.